• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T 细胞胆固醇外流可抑制细胞凋亡和衰老,增加中年小鼠的动脉粥样硬化。

T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice.

机构信息

Department of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.

Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität, 80336, Munich, Germany.

出版信息

Nat Commun. 2022 Jul 1;13(1):3799. doi: 10.1038/s41467-022-31135-4.

DOI:10.1038/s41467-022-31135-4
PMID:35778407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9249754/
Abstract

Atherosclerosis is a chronic inflammatory disease driven by hypercholesterolemia. During aging, T cells accumulate cholesterol, potentially affecting inflammation. However, the effect of cholesterol efflux pathways mediated by ATP-binding cassette A1 and G1 (ABCA1/ABCG1) on T cell-dependent age-related inflammation and atherosclerosis remains poorly understood. In this study, we generate mice with T cell-specific Abca1/Abcg1-deficiency on the low-density-lipoprotein-receptor deficient (Ldlr) background. T cell Abca1/Abcg1-deficiency decreases blood, lymph node, and splenic T cells, and increases T cell activation and apoptosis. T cell Abca1/Abcg1-deficiency induces a premature T cell aging phenotype in middle-aged (12-13 months) Ldlr mice, reflected by upregulation of senescence markers. Despite T cell senescence and enhanced T cell activation, T cell Abca1/Abcg1-deficiency decreases atherosclerosis and aortic inflammation in middle-aged Ldlr mice, accompanied by decreased T cells in atherosclerotic plaques. We attribute these effects to T cell apoptosis downstream of T cell activation, compromising T cell functionality. Collectively, we show that T cell cholesterol efflux pathways suppress T cell apoptosis and senescence, and induce atherosclerosis in middle-aged Ldlr mice.

摘要

动脉粥样硬化是一种由高血脂驱动的慢性炎症性疾病。在衰老过程中,T 细胞会积累胆固醇,这可能会影响炎症。然而,ATP 结合盒转运蛋白 A1 和 G1(ABCA1/ABCG1)介导的胆固醇外排途径对 T 细胞依赖性年龄相关性炎症和动脉粥样硬化的影响仍知之甚少。在这项研究中,我们在低密度脂蛋白受体缺陷(Ldlr)背景下生成了 T 细胞特异性 Abca1/Abcg1 缺陷的小鼠。T 细胞 Abca1/Abcg1 缺陷会减少血液、淋巴结和脾脏中的 T 细胞,并增加 T 细胞的激活和凋亡。T 细胞 Abca1/Abcg1 缺陷会诱导中年(12-13 个月)Ldlr 小鼠中出现 T 细胞过早衰老表型,这反映在衰老标志物的上调上。尽管 T 细胞衰老和 T 细胞激活增强,但 T 细胞 Abca1/Abcg1 缺陷会减少中年 Ldlr 小鼠的动脉粥样硬化和主动脉炎症,同时斑块中的 T 细胞减少。我们将这些影响归因于 T 细胞激活下游的 T 细胞凋亡,从而损害 T 细胞功能。总之,我们表明 T 细胞胆固醇外排途径可抑制 T 细胞凋亡和衰老,并在中年 Ldlr 小鼠中诱导动脉粥样硬化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/bc3fafcad3e3/41467_2022_31135_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/a31bd37c070b/41467_2022_31135_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/c6b78cf84ac8/41467_2022_31135_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/91047a5f0328/41467_2022_31135_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/935c01417781/41467_2022_31135_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/b23bea43bdd7/41467_2022_31135_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/0e63738ecba4/41467_2022_31135_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/d68d8bf723b6/41467_2022_31135_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/55a5705206d3/41467_2022_31135_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/ff5b576ba9ba/41467_2022_31135_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/bc3fafcad3e3/41467_2022_31135_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/a31bd37c070b/41467_2022_31135_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/c6b78cf84ac8/41467_2022_31135_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/91047a5f0328/41467_2022_31135_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/935c01417781/41467_2022_31135_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/b23bea43bdd7/41467_2022_31135_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/0e63738ecba4/41467_2022_31135_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/d68d8bf723b6/41467_2022_31135_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/55a5705206d3/41467_2022_31135_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/ff5b576ba9ba/41467_2022_31135_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7603/9249754/bc3fafcad3e3/41467_2022_31135_Fig10_HTML.jpg

相似文献

1
T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice.T 细胞胆固醇外流可抑制细胞凋亡和衰老,增加中年小鼠的动脉粥样硬化。
Nat Commun. 2022 Jul 1;13(1):3799. doi: 10.1038/s41467-022-31135-4.
2
Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.内皮细胞中ATP结合盒转运蛋白A1和G1的缺乏加速小鼠动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1328-37. doi: 10.1161/ATVBAHA.115.306670. Epub 2016 May 19.
3
Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.肝 X 受体的激活可减少骨髓细胞中载脂蛋白 B 基因缺陷小鼠的动脉粥样硬化,而不依赖于载脂蛋白 B 基因缺陷小鼠的骨髓细胞中的 ATP 结合盒转运蛋白 A1 和 G1。
Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):279-84. doi: 10.1161/ATVBAHA.113.302781. Epub 2013 Dec 5.
4
Specific Loss of ABCA1 (ATP-Binding Cassette Transporter A1) Suppresses TCR (T-Cell Receptor) Signaling and Provides Protection Against Atherosclerosis.ABCA1(三磷酸腺苷结合盒转运蛋白 A1)的特异性缺失抑制 TCR(T 细胞受体)信号传导并提供抗动脉粥样硬化保护。
Arterioscler Thromb Vasc Biol. 2022 Dec;42(12):e311-e326. doi: 10.1161/ATVBAHA.122.318226. Epub 2022 Oct 13.
5
Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice.巨噬细胞中三磷酸腺苷结合盒转运体 A1 和 G1 的缺乏会增加炎症反应,并加速小鼠动脉粥样硬化的形成。
Circ Res. 2013 May 24;112(11):1456-65. doi: 10.1161/CIRCRESAHA.113.301086. Epub 2013 Apr 9.
6
ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.三磷酸腺苷结合盒转运体 A1 和 G1、高密度脂蛋白代谢、胆固醇流出和炎症:动脉粥样硬化治疗的重要靶点。
Curr Drug Targets. 2011 May;12(5):647-60. doi: 10.2174/138945011795378522.
7
Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.低密度脂蛋白受体的基因缺失会损害固醇诱导的小鼠巨噬细胞ABCA1表达。一种新的依赖于固醇调节元件结合蛋白1的机制。
J Biol Chem. 2008 Jan 25;283(4):2129-38. doi: 10.1074/jbc.M706636200. Epub 2007 Nov 20.
8
Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.ABCA1和ABCG1联合缺陷促进小鼠体内泡沫细胞积累并加速动脉粥样硬化。
J Clin Invest. 2007 Dec;117(12):3900-8. doi: 10.1172/JCI33372.
9
Impact of bone marrow ATP-binding cassette transporter A1 deficiency on atherogenesis is independent of the presence of the low-density lipoprotein receptor.骨髓三磷酸腺苷结合盒转运体 A1 缺乏对动脉粥样硬化形成的影响不依赖于低密度脂蛋白受体的存在。
Atherosclerosis. 2021 Feb;319:79-85. doi: 10.1016/j.atherosclerosis.2021.01.001. Epub 2021 Jan 14.
10
ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis.ABCA1 和 ABCG1 作为预防动脉粥样硬化的潜在治疗靶点。
J Pharmacol Sci. 2022 Feb;148(2):197-203. doi: 10.1016/j.jphs.2021.11.005. Epub 2021 Dec 1.

引用本文的文献

1
Knockdown of the snoRNA-Jouvence Blocks the Proliferation and Leads to the Death of Human Primary Glioblastoma Cells.小核仁RNA-Jouvence的敲低可阻断人原发性胶质母细胞瘤细胞的增殖并导致其死亡。
Noncoding RNA. 2025 Jul 18;11(4):54. doi: 10.3390/ncrna11040054.
2
Atheroprotective Immunity and Interleukin-10 Linked to Reduced Characteristics of Plaque Stability.抗动脉粥样硬化免疫与白细胞介素-10与斑块稳定性特征降低有关。
JACC Basic Transl Sci. 2025 Jul 16;10(8):101322. doi: 10.1016/j.jacbts.2025.101322.
3
Dysregulation of cholesterol homeostasis in cancer pathogenesis.

本文引用的文献

1
Histone deacetylase 3 represses cholesterol efflux during CD4 T-cell activation.组蛋白去乙酰化酶 3 在 CD4 T 细胞活化过程中抑制胆固醇外流。
Elife. 2021 Dec 2;10:e70978. doi: 10.7554/eLife.70978.
2
Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis.动脉粥样硬化通过破坏糖酵解损害初始CD4 T细胞反应。
Arterioscler Thromb Vasc Biol. 2021 Sep;41(9):2387-2398. doi: 10.1161/ATVBAHA.120.314189. Epub 2021 Jul 29.
3
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.AIM2 炎性体加剧克隆性造血中的动脉粥样硬化。
癌症发病机制中胆固醇稳态的失调。
Cell Mol Life Sci. 2025 Apr 21;82(1):168. doi: 10.1007/s00018-025-05617-9.
4
Metabolic reprogramming in T cell senescence: a novel strategy for cancer immunotherapy.T细胞衰老中的代谢重编程:癌症免疫治疗的新策略。
Cell Death Discov. 2025 Apr 9;11(1):161. doi: 10.1038/s41420-025-02468-y.
5
Dissecting Causal Relationship Among Immune Cells, Plasma Metabolites and Coronary Atherosclerosis: A Mendelian Randomization Study.剖析免疫细胞、血浆代谢物与冠状动脉粥样硬化之间的因果关系:一项孟德尔随机化研究
Immunotargets Ther. 2025 Mar 6;14:175-188. doi: 10.2147/ITT.S508042. eCollection 2025.
6
Cholesterol efflux protein, ABCA1, supports anti-cancer functions of myeloid immune cells.胆固醇流出蛋白ABCA1支持髓系免疫细胞的抗癌功能。
bioRxiv. 2025 Feb 19:2025.02.19.638515. doi: 10.1101/2025.02.19.638515.
7
SMC Abca1 and Abcg1 Deficiency Enhances Urinary Bladder Distension but Not Atherosclerosis.平滑肌细胞Abca1和Abcg1缺乏增强膀胱扩张但不影响动脉粥样硬化。
Circ Res. 2025 Feb 28;136(5):491-507. doi: 10.1161/CIRCRESAHA.124.325103. Epub 2025 Feb 11.
8
Inflammaging, a targetable pathway for preventing cardiovascular diseases.炎症衰老,一种可靶向的预防心血管疾病的途径。
Cardiovasc Res. 2024 Nov 12. doi: 10.1093/cvr/cvae240.
9
The role of T cells in vascular aging, hypertension, and atherosclerosis.T 细胞在血管老化、高血压和动脉粥样硬化中的作用。
Am J Physiol Heart Circ Physiol. 2024 Dec 1;327(6):H1345-H1360. doi: 10.1152/ajpheart.00570.2024. Epub 2024 Oct 18.
10
Immunometabolism in atherosclerotic disorders.动脉粥样硬化疾病中的免疫代谢。
Nat Cardiovasc Res. 2024 Jun;3(6):637-650. doi: 10.1038/s44161-024-00473-5. Epub 2024 May 23.
Nature. 2021 Apr;592(7853):296-301. doi: 10.1038/s41586-021-03341-5. Epub 2021 Mar 17.
4
NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients.NLRP3炎性小体导致慢性HIV-1感染患者的CD4+ T细胞损失。
J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI138861.
5
Potentiating CD8 T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling.通过抑制 PCSK9 增强 CD8 T 细胞抗肿瘤活性,以促进 LDLR 介导的 TCR 循环和信号转导。
Protein Cell. 2021 Apr;12(4):240-260. doi: 10.1007/s13238-021-00821-2. Epub 2021 Feb 19.
6
Nuclear receptor LXRβ controls fitness and functionality of activated T cells.核受体 LXRβ 控制活化 T 细胞的适应性和功能。
J Exp Med. 2021 Apr 5;218(4). doi: 10.1084/jem.20201311.
7
Heterogeneity of T Cells in Atherosclerosis Defined by Single-Cell RNA-Sequencing and Cytometry by Time of Flight.单细胞 RNA 测序和飞行时间流式细胞术定义的动脉粥样硬化中的 T 细胞异质性。
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):549-563. doi: 10.1161/ATVBAHA.120.312137. Epub 2020 Dec 3.
8
Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics.单细胞转录组学解析人动脉粥样硬化斑块的微观解剖结构。
Circ Res. 2020 Nov 6;127(11):1437-1455. doi: 10.1161/CIRCRESAHA.120.316770. Epub 2020 Sep 28.
9
Liver X receptors are required for thymic resilience and T cell output.肝 X 受体对于胸腺的恢复和 T 细胞的输出是必需的。
J Exp Med. 2020 Oct 5;217(10). doi: 10.1084/jem.20200318.
10
Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development.T 细胞受体介导的信号通路在 T 细胞激活和发育中的最新研究进展。
Exp Mol Med. 2020 May;52(5):750-761. doi: 10.1038/s12276-020-0435-8. Epub 2020 May 21.